The similarity between atherosclerotic plaque formation in rabbits and humans has been documented elsewhere. [38] [39] [40] [41] We suggest that the observed differences in the uptake of DM-and D-USPIO by rabbit atherosclerotic lesions are attributable to the binding of mannan to USPIO. Further study is required to investigate the stability of bound mannan and to determine optimum dosage amounts.